MedPath

Can a novel fibre supplement improve gut symptoms and well-being in athletes and community members with gut complaints?

Not Applicable
Conditions
Gut Health
Gut Microbiome
Gut Transit Time
Mental Health
Dietary Fibre
Diet and Nutrition - Other diet and nutrition disorders
Mental Health - Anxiety
Oral and Gastrointestinal - Normal oral and gastrointestinal development and function
Public Health - Health promotion/education
Metabolic and Endocrine - Normal metabolism and endocrine development and function
Registration Number
ACTRN12624000505505
Lead Sponsor
Edith Cowan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion criteria

Both groups of Community members and athletes:
1)Aged 18 - 65 years old;
2)Available to attend local clinic visits at ECU Joondalup and willing to consume the intervention dietary formula;
3)Have self-reported GI symptoms (mild to severe) within at least 3 months prior to the commencement of the study.

Community members:
1) Healthy adults with < 3 hours per week of moderate and high intensity physical activity (e.g. jogging, running, fitness classes in the gym, Pilates)

Athletes:
1). Be either a long-distance runner and/or triathlete and currently following a periodised training plan which, at peak, involved performing greater than 10 hours of training each week and including greater than 90 minutes endurance training each week.

Exclusion Criteria

1) Current smoker
2) Pregnant or planning to become pregnant;
3) Breastfeeding;
4) Have a known diagnosis of other gastrointestinal illness (e.g. Inflammatory Bowel Disease, bowel resection, coeliac disease);
5) Previous abdominal or gastrointestinal surgeries that affect GI function and absorption;
6) Have been taking antibiotics in the past four weeks
7) Have been taking other medication to modify or treat chronic GI illness, or mental health conditions;
8) Renal or hepatic diseases, and/or other major medical illness, condition or habit that may interfere with completion of the study.
9) Have been under severe mental health conditions, which is indicated by the DASS-21, mental health questionnaire.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath